Name | 3,4-dihydro-2H-2,7-naphthyridin-1-one |
---|---|
Synonyms |
3,4-dihydro-2H-[2,7]naphthyridine-1-one
3,4-DIHYDRO-2H-[2,7]NAPHTHYRIDIN-1-ONE 3,4-dihydro-2H-[2,7]naphthyridin-1-on 1,2,3,4-TETRAHYDRO-2,7-NAPHTHYRIDIN-1-ONE 3,4-DIHYDRO-2,7-NAPHTHYRIDIN-1(2H)-ONE |
Molecular Formula | C8H8N2O |
---|---|
Molecular Weight | 148.16200 |
Exact Mass | 148.06400 |
PSA | 45.48000 |
LogP | 0.37790 |
~73% 858120-58-8 |
Literature: NOVARTIS AG; Bock, Mark Gary; Gaul, Christoph; Gummadi, Venkateshwar Rao; Moebitz, Henrik; Sengupta, Saumitra Patent: US2014/45872 A1, 2014 ; Location in patent: Paragraph 0985 ; |
~20% 858120-58-8 |
Literature: Galli, Ubaldina; Mesenzani, Ornella; Coppo, Camilla; Sorba, Giovanni; Canonico, Pier Luigi; Tron, Gian Cesare; Genazzani, Armando A. European Journal of Medicinal Chemistry, 2012 , vol. 55, p. 58 - 66,9 |
~% 858120-58-8 |
Literature: Galli, Ubaldina; Mesenzani, Ornella; Coppo, Camilla; Sorba, Giovanni; Canonico, Pier Luigi; Tron, Gian Cesare; Genazzani, Armando A. European Journal of Medicinal Chemistry, 2012 , vol. 55, p. 58 - 66,9 |
~% 858120-58-8 |
Literature: Galli, Ubaldina; Mesenzani, Ornella; Coppo, Camilla; Sorba, Giovanni; Canonico, Pier Luigi; Tron, Gian Cesare; Genazzani, Armando A. European Journal of Medicinal Chemistry, 2012 , vol. 55, p. 58 - 66,9 |
~% 858120-58-8 |
Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1 |
~% 858120-58-8 |
Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1 |
~% 858120-58-8 |
Literature: NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1 |